
PICU Doc On Call Don’t Poke It, Spray It: The Intranasal Medication Playbook
Mar 29, 2026
A clinical case of a four-month-old needing MRI sedation sparks a discussion of needle-free intranasal drug use. They explore nasal anatomy and pharmacology that enable rapid nose-to-brain delivery. Practical tips cover atomizer technique, dosing limits per nostril, and how intranasal options compare with oral and IV routes. Common pediatric intranasal drugs and monitoring considerations are reviewed.
AI Snips
Chapters
Transcript
Episode notes
Infant MRI Without IV Using Intranasal Sedation
- A four-month-old infant with a prenatally detected brain cyst needed a 40-minute MRI and feeding/bundling failed because she wasn't hungry.
- The sedation team chose intranasal medications to avoid placing a peripheral IV for a non-contrast short MRI, prioritizing family preference and minimal invasiveness.
Nose Brain Pathway Enables Rapid CNS Delivery
- Intranasal drugs reach systemic circulation via highly vascular nasal mucosa and can access the CNS directly through olfactory and trigeminal pathways.
- Drugs may bypass the blood-brain barrier and reach CSF rapidly, sometimes faster than IV, but inflamed mucosa or vasoconstrictors limit absorption.
Administer Intranasal Drugs With An Atomizer Upright
- Use an atomizer to convert medication into a 30–100 micron mist, seat the patient upright, and angle the tip away from the septum for optimal mucosal absorption.
- Divide doses so ≤1 mL per nostril, spray each nare separately, and approach from the side to minimize patient anxiety.
